Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Statin use and risk of diabetes-reply.

Culver AL, Ockene IS, Ma Y.

Arch Intern Med. 2012 Jun 11;172(11):896-7. doi: 10.1001/archinternmed.2012.1613. No abstract available.

PMID:
23752696
3.

Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM.

Diabetes Care. 2009 Oct;32(10):1924-9. doi: 10.2337/dc09-0738.

4.

Patterns and predictors of statin prescription in patients with type 2 diabetes.

Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

Cardiovasc Diabetol. 2009 May 13;8:25. doi: 10.1186/1475-2840-8-25.

5.

Statins, risk of diabetes, and implications on outcomes in the general population.

Wang KL, Liu CJ, Chao TF, Huang CM, Wu CH, Chen SJ, Chen TJ, Lin SJ, Chiang CE.

J Am Coll Cardiol. 2012 Oct 2;60(14):1231-8. doi: 10.1016/j.jacc.2012.05.019. Epub 2012 Aug 8.

6.

Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.

Shepherd J, Betteridge J, Van Gaal L; European Consensus Panel..

Curr Med Res Opin. 2005 May;21(5):665-82. Review.

PMID:
15969866
7.

Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.

Sampalis JS, Bissonnette S, Habib R, Boukas S; Ezetrol Add-On Investigators..

Ann Pharmacother. 2007 Sep;41(9):1345-51. Epub 2007 Jul 31.

PMID:
17666579
8.

Age-related cataract is associated with type 2 diabetes and statin use.

Machan CM, Hrynchak PK, Irving EL.

Optom Vis Sci. 2012 Aug;89(8):1165-71. doi: 10.1097/OPX.0b013e3182644cd1.

PMID:
22797512
9.

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators..

Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x.

PMID:
21679231
10.

Statins and the risk of new-onset diabetes: a review of recent evidence.

Preiss D, Sattar N.

Curr Opin Lipidol. 2011 Dec;22(6):460-6. doi: 10.1097/MOL.0b013e32834b4994. Review.

PMID:
21897230
11.

Statin use and the risk of incident diabetes mellitus: a review of the literature.

Colbert JD, Stone JA.

Can J Cardiol. 2012 Sep-Oct;28(5):581-9. doi: 10.1016/j.cjca.2012.03.021. Epub 2012 Jun 1. Review.

PMID:
22658337
12.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
14.

Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.

Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahilly-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y.

Arch Intern Med. 2012 Jan 23;172(2):144-52. doi: 10.1001/archinternmed.2011.625. Epub 2012 Jan 9.

PMID:
22231607
15.

Statin use in Canadians: trends, determinants and persistence.

Neutel CI, Morrison H, Campbell NR, de Groh M.

Can J Public Health. 2007 Sep-Oct;98(5):412-6.

PMID:
17985686
16.
18.

Erectile dysfunction and statin treatment in high cardiovascular risk patients.

Solomon H, Samarasinghe YP, Feher MD, Man J, Rivas-Toro H, Lumb PJ, Wierzbicki AS, Jackson G.

Int J Clin Pract. 2006 Feb;60(2):141-5.

PMID:
16451283
19.

Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.

Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, Christianson TJ, Mullan RJ, Smith SA.

Arch Intern Med. 2007 May 28;167(10):1076-82.

PMID:
17533211
20.

Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes.

Zhang Q, Safford M, Miller D, Crystal S, Rajan M, Tseng CL, Pogach L.

Med Care. 2007 Apr;45(4):308-14.

PMID:
17496714

Supplemental Content

Support Center